Nippon Chemiphar Co., Ltd.

Chemiphar has remained in operating profit in the second quarter of its 2024 financial year compared to same period last year, after previously celebrating its return to profit earlier this year. The

In the ever-evolving global generics and biosimilars industry, one constant that can be relied upon is change. Even as the upheaval of the COVID-19 pandemic recedes, fresh political and economic press

Japan’s Nippon Chemiphar has announced a collaboration with global development institution the International Finance Corporation that will see the two organizations work together to boost local prod

After its third strong quarter in a row, Nippon Chemiphar Co., Ltd. has revised upwards its forecasts for its FY2021 financial year ending 31 March 2022, anticipating an extra ¥1bn ($8.7m) in sales